Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alzinova AB (ALZ) Stock Price & Analysis

2 Followers

ALZ Stock Chart & Stats

kr 0.32-kr 0.02(-5.34%)
At close: 5:30 PM GMT+1
kr 0.5kr 0.75kr 1Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
SEK 0.31 - SEK 0.35
52-Week Range
SEK 0.31 - SEK 2.01
Previous Close
SEK 0.34
Volume
N/A
Average Volume (3M)
2.34M
Market Cap
SEK 106.67M
Enterprise Value
SEK 66.43M
Total Cash (Recent Filing)
SEK 13.31M
Total Debt (Recent Filing)
SEK 800.00K
Price to Earnings (P/E)
―
Beta
0.67
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Minimal Leverage

Alzinova’s very low debt burden limits financial risk and reduces the cash required for interest or debt repayment. This gives the company greater flexibility to direct available resources toward Alzheimer’s research and provides a stronger buffer while development programs remain unprofitable.

Growing Equity Funding Base

The larger equity base strengthens Alzinova’s capacity to fund ongoing development and absorb operating losses without relying heavily on debt. Although equity funding does not solve profitability, it provides a more durable financial foundation for advancing candidates through clinical development.

Focused Alzheimer’s Platform

A focused immunotherapy strategy gives Alzinova a defined development identity and concentrates resources on a specific Alzheimer’s disease mechanism. Its lead program is designed for a targeted immune response, while the stated out-licensing or commercialization goal creates a potential path to future scale.

Bears Say

Persistent Cash Burn

Sustained negative operating and free cash flow means Alzinova cannot currently fund operations and investment internally. Continued cash burn increases dependence on external financing and may constrain development choices over the next several quarters if funding conditions or investor support weaken.

Deep Operating Losses

Material operating and net losses show that the business has not yet converted its research platform into sustainable earnings. Persistent deficits reduce financial resilience, require continued capital support, and make future progress dependent on successful development and eventual commercial or licensing outcomes.

Weak And Volatile Revenue

Low and inconsistent revenue provides little evidence of a stable commercial base supporting the business today. Revenue volatility makes planning and resource allocation more difficult, while the reported negative growth reinforces that near-term financial performance remains dependent on funding rather than operating scale.

ALZ FAQ

What was Alzinova AB’s price range in the past 12 months?
Alzinova AB lowest stock price was kr 0.31 and its highest was kr 2.01 in the past 12 months.
What is Alzinova AB’s market cap?
Alzinova AB’s market cap is kr 106.67M.
When is Alzinova AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alzinova AB’s earnings last quarter?
Alzinova AB released its earnings results on Aug 20, 2026. The company reported -kr 0.033 earnings per share for the quarter.
Is Alzinova AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Alzinova AB pay dividends?
Alzinova AB does not currently pay dividends.
What is Alzinova AB’s EPS estimate?
Alzinova AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzinova AB have?
Alzinova AB has 316,059,420 shares outstanding.
What happened to Alzinova AB’s price movement after its last earnings report?
Alzinova AB reported an EPS of -kr 0.033 in its last earnings report. Following the earnings report the stock price went down -6.925%.
Which hedge fund is a major shareholder of Alzinova AB?
Currently, no hedge funds are holding shares in SE:ALZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology